Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued on Sunday. The firm set a “hold” rating on the ...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly ...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any ...

US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any ...

Sorrento Therapeutics, Inc. (SRNEQ) announced today positive Phase 2a top-line clinical trial results for the RTX program.The Phase 2a study follows the positive observations from... Sorrento ...

TIAA-CREF Life Funds - Nuveen Life Stock Index Fund 0.00% NaN Dec 31, 2024 0.00 Vanguard Investments Funds ICVC - Vanguard FTSE Global All Cap Index Fund 0.00% NaN Dec 31, 2024 0.00 ...